BioMed Research International / 2015 / Article / Tab 1

Research Article

A New Methodology for Evaluation of Nematode Viability

Table 1

IC50 drugs: ivermectin and albendazole sulfoxide, using different fluorimetric markers and motility test (means of times 48 and 72 hours). Different letters in the lines demonstrate that the means are different () according to Tukey test and -test.

Drug IC50 P. iodideIC50 SytoxIC50 motility

Ivermectin 132.4 µM ± 5.3a 261.4 µM ± 23.7b 0.87 µM ± 0.05c
Albendazole sulfoxide 214.9 µM ± 100.2a 874.5 µM ± 67.50b

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.